Enterprise Products Partners LP
LSE:0S23
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Enterprise Products Partners LP
LSE:0S23
|
US |
|
WuXi Biologics (Cayman) Inc
F:1FW1
|
CN |
|
S
|
Sunstone Hotel Investors Inc
SWB:UF2
|
US |
|
A
|
Aptose Biosciences Inc
F:LTIA
|
CA |
|
A
|
American Water Works Company Inc
DUS:AWC
|
US |
|
Italgas SpA
MIL:IG
|
IT |
|
ANSYS Inc
NASDAQ:ANSS
|
US |
Wall St Price Targets
0S23 Price Targets Summary
Enterprise Products Partners LP
According to Wall Street analysts, the average 1-year price target for 0S23 is 41.5941 USD with a low forecast of 35.0442 USD and a high forecast of 47.0024 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0S23's stock price target?
Price Target
41.5941
USD
According to Wall Street analysts, the average 1-year price target for 0S23 is 41.5941 USD with a low forecast of 35.0442 USD and a high forecast of 47.0024 USD.
What is the Revenue forecast for Enterprise Products Partners LP?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 5 years is 4%.
What is the Operating Income forecast for Enterprise Products Partners LP?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 6 years is 5%.
What is the Net Income forecast for Enterprise Products Partners LP?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 6 years is 6%.
